Unveiling Novel Urease Inhibitors for <i>Helicobacter pylori</i>: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations

Simple item page
dc.contributor.authorValenzuela-Hormazabal, Paulina
dc.contributor.authorSepulveda, Romina V.
dc.contributor.authorAlegria-Arcos, Melissa
dc.contributor.authorValdes-Munoz, Elizabeth
dc.contributor.authorRojas-Perez, Victor
dc.contributor.authorGonzalez-Bonet, Ileana
dc.contributor.authorSuardiaz, Reynier
dc.contributor.authorGalarza, Christian
dc.contributor.authorMorales, Natalia
dc.contributor.authorLeddermann, Veronica
dc.contributor.authorCastro, Ricardo I.
dc.contributor.authorBenso, Bruna
dc.contributor.authorUrra, Gabriela
dc.contributor.authorHernandez-Rodriguez, Erix W.
dc.contributor.authorBustos, Daniel
dc.date.accessioned2025-01-20T17:08:28Z
dc.date.available2025-01-20T17:08:28Z
dc.date.issued2024
dc.description.abstractHelicobacter pylori (Hp) infections pose a global health challenge demanding innovative therapeutic strategies by which to eradicate them. Urease, a key Hp virulence factor hydrolyzes urea, facilitating bacterial survival in the acidic gastric environment. In this study, a multi-methodological approach combining pharmacophore- and structure-based virtual screening, molecular dynamics simulations, and MM-GBSA calculations was employed to identify novel inhibitors for Hp urease (HpU). A refined dataset of 8,271,505 small molecules from the ZINC15 database underwent pharmacokinetic and physicochemical filtering, resulting in 16% of compounds for pharmacophore-based virtual screening. Molecular docking simulations were performed in successive stages, utilizing HTVS, SP, and XP algorithms. Subsequent energetic re-scoring with MM-GBSA identified promising candidates interacting with distinct urease variants. Lys219, a residue critical for urea catalysis at the urease binding site, can manifest in two forms, neutral (LYN) or carbamylated (KCX). Notably, the evaluated molecules demonstrated different interaction and energetic patterns in both protein variants. Further evaluation through ADMET predictions highlighted compounds with favorable pharmacological profiles, leading to the identification of 15 candidates. Molecular dynamics simulations revealed comparable structural stability to the control DJM, with candidates 5, 8 and 12 (CA5, CA8, and CA12, respectively) exhibiting the lowest binding free energies. These inhibitors suggest a chelating capacity that is crucial for urease inhibition. The analysis underscores the potential of CA5, CA8, and CA12 as novel HpU inhibitors. Finally, we compare our candidates with the chemical space of urease inhibitors finding physicochemical similarities with potent agents such as thiourea.
dc.description.funderANID FONDECYT de Iniciacin
dc.fuente.origenWOS
dc.identifier.doi10.3390/ijms25041968
dc.identifier.eissn1422-0067
dc.identifier.issn1661-6596
dc.identifier.urihttps://doi.org/10.3390/ijms25041968
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/90953
dc.identifier.wosidWOS:001174742800001
dc.issue.numero4
dc.language.isoen
dc.revistaInternational journal of molecular sciences
dc.rightsacceso restringido
dc.subjectcomputer-aided drug design
dc.subjectstructure-based virtual screening
dc.subjectpharmacophore-based virtual screening
dc.subjectmolecular dynamics simulations
dc.subjectADMET
dc.subjecturease
dc.subjectHelicobacter pylori
dc.titleUnveiling Novel Urease Inhibitors for <i>Helicobacter pylori</i>: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations
dc.typeartículo
dc.volumen25
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Unveiling Novel Urease Inhibitors for Helicobacter pylori.pdf
Size:
2.55 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas